Matches in SemOpenAlex for { <https://semopenalex.org/work/W1569453151> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- W1569453151 endingPage "2929" @default.
- W1569453151 startingPage "2929" @default.
- W1569453151 abstract "THIRTY YEARS AGO, CONFIDENCE IN US science and technology soared. A victory in the space race and two decades of steady economic expansion drove expectations for US achievement ever skyward. Philanthropist Mary Lasker saw an opportunity to turn these resources against the scourge of cancer. With Texas Sen Ralph Yarborough and other proponents, Lasker spearheaded a movement to establish a sweeping national campaign against cancer. Their efforts culminated in the National Cancer Act of 1971, signed into law by President Richard Nixon on December 23. The act greatly augmented the budget and independence of the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) in Bethesda, Md. Breaking from precedent, NCI directors became presidential appointees with the authority to propose budgets directly to Congress. With these provisions secured, Nixon declared the “conquest of cancer a national crusade,” spurring widespread expectations for a quick victory. Cancer turned out to be much wilier than anticipated. The overall cancer death rate climbed through the 1970s and 1980s, leading to disappointment in the “failed war,” as some politicians and health policymakers called it. But in 1992, the trend leveled off, and overall cancer death rates began declining in 1994. Gains against some individual cancers have been substantial. Samuel Broder, MD, is in a unique position to reflect on this progress. He joined the NCI in 1972, rising as a top scientist and leading the team that discovered the therapeutic potential of one of the first HIV/AIDS drugs, AZT. He headed the agency from 1988 to 1995. Broder now serves as executive vice president and chief medical officer of Celera Genomics, Rockville, Md." @default.
- W1569453151 created "2016-06-24" @default.
- W1569453151 date "2001-12-19" @default.
- W1569453151 modified "2023-09-24" @default.
- W1569453151 title "Samuel Broder, MD, Reflects on the 30th Anniversary of the National Cancer Act" @default.
- W1569453151 doi "https://doi.org/10.1001/jama.286.23.2929" @default.
- W1569453151 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11743814" @default.
- W1569453151 hasPublicationYear "2001" @default.
- W1569453151 type Work @default.
- W1569453151 sameAs 1569453151 @default.
- W1569453151 citedByCount "0" @default.
- W1569453151 crossrefType "journal-article" @default.
- W1569453151 hasConcept C121608353 @default.
- W1569453151 hasConcept C126322002 @default.
- W1569453151 hasConcept C512399662 @default.
- W1569453151 hasConcept C71924100 @default.
- W1569453151 hasConceptScore W1569453151C121608353 @default.
- W1569453151 hasConceptScore W1569453151C126322002 @default.
- W1569453151 hasConceptScore W1569453151C512399662 @default.
- W1569453151 hasConceptScore W1569453151C71924100 @default.
- W1569453151 hasIssue "23" @default.
- W1569453151 hasLocation W15694531511 @default.
- W1569453151 hasLocation W15694531512 @default.
- W1569453151 hasOpenAccess W1569453151 @default.
- W1569453151 hasPrimaryLocation W15694531511 @default.
- W1569453151 hasRelatedWork W2080059066 @default.
- W1569453151 hasRelatedWork W2102594276 @default.
- W1569453151 hasRelatedWork W2233387187 @default.
- W1569453151 hasRelatedWork W2340387901 @default.
- W1569453151 hasRelatedWork W2365364931 @default.
- W1569453151 hasRelatedWork W2418638721 @default.
- W1569453151 hasRelatedWork W2745025123 @default.
- W1569453151 hasRelatedWork W3170310109 @default.
- W1569453151 hasRelatedWork W3196090075 @default.
- W1569453151 hasRelatedWork W4310755028 @default.
- W1569453151 hasVolume "286" @default.
- W1569453151 isParatext "false" @default.
- W1569453151 isRetracted "false" @default.
- W1569453151 magId "1569453151" @default.
- W1569453151 workType "article" @default.